About Seneca Therapeutics
Seneca Therapeutics is a private company based in Blue Bell, Pennsylvania. It has reported $11,049,539 raised in five offerings on Form D since May 2019. Its chief executive is James Hussey.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 16, 2024 | Feb 7, 2025 | $1,636,582of $8.0M target | 68 | $24,067 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 12, 2021 | Apr 2, 2021amended Dec 23, 2022 | $7,711,958of $12.8M target | 114 | $67,649 | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Jun 12, 2020 | Jun 23, 2020 | $500,999of $3.2M target | 15 | $33,400 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 12, 2020 | Nov 22, 2019amended Mar 19, 2020 | $820,000of $1.0M target | 14 | $58,571 | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| May 15, 2019 | May 30, 2019amended Aug 8, 2019 | $380,000of $500K target | 7 | $54,286 | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Total, five offerings | $11,049,539 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Seneca Therapeutics's Form D filed Feb 7, 2025.
CD
Cuong Do
Executive officer and director
MK
Mark Kerschner
Director
PH
Paul Hallenbeck
Executive officer and director
